Minimally invasive laparoscopic treatment for gastric cancer with sigmoid colon cancer: a report of 1 case_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

YU Hualong ,  WANG Xixun ,  JIANG Lixin

The First Department of Gastrointestinal Surgery, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P. R. China;

Corresponding author：

WANG Xixun, Email: w70063@sina.com; JIANG Lixin, Email: jianglixin1969@hotmail.com

Keywords：

multiple primary cancer; gastric cancer; colon cancer; laparoscopic surgery

DOI：

10.7507/1007-9424.201907049

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize the diagnosis and treatment of a primary gastric colon cancer, and to explore its safety and feasibility.Method The clinical data of a patient with gastric cancer and sigmoid colon cancer who admitted to The Affiliated Yantai Yuding Hospital of Qingdao University in October 2017 was analyzed.Results The patient underwent laparoscopic radical gastrectomy plus π anastomosis and laparoscopic radical resection of colon cancer. The operation time was 330 min and the intraoperative blood loss was 120 mL. There were no complications such as stomach cramps and sputum after operation and he was successfully discharged on the 9^th day after surgery. Postoperative pathological staging: gastric cancer (pT3N3M0, ⅢB) and sigmoid colon cancer (pT2N0M0, Ⅰ B).Conclusions Multiple primary cancer of the simultaneous gastric colon should be diagnosed before operation. Laparoscopic minimally invasive treatment for gastric cancer with sigmoid colon cancer is safe and feasible, and can benefit patients.

Citation： YU Hualong, WANG Xixun, JIANG Lixin. Minimally invasive laparoscopic treatment for gastric cancer with sigmoid colon cancer: a report of 1 case. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(10): 1217-1221. doi: 10.7507/1007-9424.201907049 Copy

1.	陈学燕, 李利亚. 多原发恶性肿瘤临床特点及发病机制的研究进展. 中日友好医院学报, 2019, 33(1): 41-44.
2.	Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst, 2007, 99(21): 1634-1643.
3.	Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin, 2017, 67(2): 93-99.
4.	Bubien V, Bonnet F, Brouste V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet, 2013, 50(4): 255-263.
5.	Molina-Montes E, Requena M, Sánchez-Cantalejo E, et al. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol, 2015, 136(1): 158-171.
6.	Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem, 2014, 60(8): 1062-1072.
7.	Braisch U, Meyer M, Radespiel-Tröger M. Risk of tobacco-related multiple primary cancers in Bavaria, Germany. BMC Cancer, 2012, 12: 250.
8.	奥婷, 孙军平, 张明月, 等. 肺癌合并其他原发恶性肿瘤 55 例发病特点分析. 解放军医学院学报, 2016, 37(3): 226-228, 241.
9.	Utada M, Ohno Y, Hori M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers. Cancer Sci, 2014, 105(7): 890-896.
10.	宋诗平, 赵越, 王春玉. 雌激素受体在甲状腺癌中作用的研究进展. 生命科学, 2017, 29(5): 489-494.
11.	Noguchi M, Naruki Y, Matsuo K, et al. A case report of triple malignant tumor including early gastric carcinoma–multiple primary malignant tumors, a survey of the literatures and a statistical study (author’s transl). Nihon Shokakibyo Gakkai Zasshi, 1978, 75(1): 71-79.
12.	Jin B, Zhang S, Chuang X, et al. Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report. BMC Cancer, 2018, 18(1): 1138.
13.	兰春斌, 贾贵清, 袁浩, 等. 新辅助化疗联合完全腹腔镜下远端胃癌 D2 根治术的临床疗效. 中国临床研究, 2019, 32(6): 747-750, 754.
14.	Shoji F, Yamazaki K, Miura N, et al. Postoperative management of multiple primary cancers associated with non-small cell lung cancer. Anticancer Res, 2018, 38(6): 3773-3778.
15.	Baba Y, Yoshida N, Kinoshita K, et al. Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study. Ann Surg, 2018, 267(3): 478-483.
16.	郭锐, 李囡, 王菲, 等. ¹⁸F-FDG PET/CT 在同时性多原发癌中的应用. 肿瘤, 2018, 38(4): 371-378.
17.	徐玲玲, 顾康生. 170 例多原发恶性肿瘤的临床分析. 安徽医科大学学报, 2011, 46(12): 1318-1321.
18.	端木媛媛, 王瑞平. 王瑞平教授治疗多原发癌的经验. 中医药导报, 2018, 24(9): 53-54, 65.
19.	孙俊杰, 李双庆. 多原发癌病因及发病机制的探索. 中国全科医学, 2017, 20(9): 1136-1141.
20.	Gustafsson UO, Scott MJ, Schwenk W, et al. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations. World J Surg, 2013, 37(2): 259-284.
21.	韩伟峰, 费伯健, 高其忠, 等. ERAS 用于进展期胃癌 D2 根治术对胃肠功能恢复情况及生存质量的影响. 中华普外科手术学杂志: 电子版, 2019, 13(2): 144-147.
22.	郑权, 李晓锋, 刘盖, 等. 结直肠癌患者 ERAS 方案和术后住院时间的相关性分析. 岭南现代临床外科, 2019, 19(2): 130-134, 138.
23.	陈凛. 有关腹腔镜胃癌根治术的若干问题. 中华胃肠外科杂志, 2005, 8(5): 396-397.
24.	Reisinger KW, Schellekens DH, Bosmans JW, et al. Cyclooxygenase-2 is essential for colorectal anastomotic healing. Ann Surg, 2017, 265(3): 547-554.
25.	刘琳. 加速康复外科策略中使用帕瑞昔布钠对胃癌根治术后疼痛和早期恢复的影响. 合肥: 安徽医科大学, 2018.

1. 陈学燕, 李利亚. 多原发恶性肿瘤临床特点及发病机制的研究进展. 中日友好医院学报, 2019, 33(1): 41-44.
2. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst, 2007, 99(21): 1634-1643.
3. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin, 2017, 67(2): 93-99.
4. Bubien V, Bonnet F, Brouste V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet, 2013, 50(4): 255-263.
5. Molina-Montes E, Requena M, Sánchez-Cantalejo E, et al. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol, 2015, 136(1): 158-171.
6. Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem, 2014, 60(8): 1062-1072.
7. Braisch U, Meyer M, Radespiel-Tröger M. Risk of tobacco-related multiple primary cancers in Bavaria, Germany. BMC Cancer, 2012, 12: 250.
8. 奥婷, 孙军平, 张明月, 等. 肺癌合并其他原发恶性肿瘤 55 例发病特点分析. 解放军医学院学报, 2016, 37(3): 226-228, 241.
9. Utada M, Ohno Y, Hori M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers. Cancer Sci, 2014, 105(7): 890-896.
10. 宋诗平, 赵越, 王春玉. 雌激素受体在甲状腺癌中作用的研究进展. 生命科学, 2017, 29(5): 489-494.
11. Noguchi M, Naruki Y, Matsuo K, et al. A case report of triple malignant tumor including early gastric carcinoma–multiple primary malignant tumors, a survey of the literatures and a statistical study (author’s transl). Nihon Shokakibyo Gakkai Zasshi, 1978, 75(1): 71-79.
12. Jin B, Zhang S, Chuang X, et al. Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report. BMC Cancer, 2018, 18(1): 1138.
13. 兰春斌, 贾贵清, 袁浩, 等. 新辅助化疗联合完全腹腔镜下远端胃癌 D2 根治术的临床疗效. 中国临床研究, 2019, 32(6): 747-750, 754.
14. Shoji F, Yamazaki K, Miura N, et al. Postoperative management of multiple primary cancers associated with non-small cell lung cancer. Anticancer Res, 2018, 38(6): 3773-3778.
15. Baba Y, Yoshida N, Kinoshita K, et al. Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study. Ann Surg, 2018, 267(3): 478-483.
16. 郭锐, 李囡, 王菲, 等. ¹⁸F-FDG PET/CT 在同时性多原发癌中的应用. 肿瘤, 2018, 38(4): 371-378.
17. 徐玲玲, 顾康生. 170 例多原发恶性肿瘤的临床分析. 安徽医科大学学报, 2011, 46(12): 1318-1321.
18. 端木媛媛, 王瑞平. 王瑞平教授治疗多原发癌的经验. 中医药导报, 2018, 24(9): 53-54, 65.
19. 孙俊杰, 李双庆. 多原发癌病因及发病机制的探索. 中国全科医学, 2017, 20(9): 1136-1141.
20. Gustafsson UO, Scott MJ, Schwenk W, et al. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations. World J Surg, 2013, 37(2): 259-284.
21. 韩伟峰, 费伯健, 高其忠, 等. ERAS 用于进展期胃癌 D2 根治术对胃肠功能恢复情况及生存质量的影响. 中华普外科手术学杂志: 电子版, 2019, 13(2): 144-147.
22. 郑权, 李晓锋, 刘盖, 等. 结直肠癌患者 ERAS 方案和术后住院时间的相关性分析. 岭南现代临床外科, 2019, 19(2): 130-134, 138.
23. 陈凛. 有关腹腔镜胃癌根治术的若干问题. 中华胃肠外科杂志, 2005, 8(5): 396-397.
24. Reisinger KW, Schellekens DH, Bosmans JW, et al. Cyclooxygenase-2 is essential for colorectal anastomotic healing. Ann Surg, 2017, 265(3): 547-554.
25. 刘琳. 加速康复外科策略中使用帕瑞昔布钠对胃癌根治术后疼痛和早期恢复的影响. 合肥: 安徽医科大学, 2018.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Minimally invasive laparoscopic treatment for gastric cancer with sigmoid colon cancer: a report of 1 case

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content